Researcher Profile
Researcher Profile
Elizabeth Finch, MD
Assistant Professor, Department of Pediatrics
Division of Hematology and Oncology
Division of Hematology and Oncology
Scientific Program:Next-Generation Therapies
Research Interests
- Pediatrics
- Glioma
- Therapeutics
- Neoplasms
- Immunotherapy
- Central Nervous System Neoplasms
- National Cancer Institute (U.S.)
- Vemurafenib
- Histones
- Education
- Mutation
- Drug Therapy
Recent Publications
2020
Finch, EA, Duke, E, Hwang, EI & Packer, RJ 2020, 'Immunotherapy Approaches for Pediatric CNS Tumors and Associated Neurotoxicity', Pediatric Neurology, vol. 107, pp. 7-15. https://doi.org/10.1016/j.pediatrneurol.2020.01.004
Theeler, BJ, Dalal, Y, Monje, M, Shilatifard, A, SuvĂ , ML, Aboud, O, Camphausen, K, Cordova, C, Finch, E, Heiss, JD, Packer, RJ, Romo, CG, Aldape, K, Penas-Prado, M, Armstrong, T & Gilbert, MR 2020, 'NCI-CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors - Histone Mutated Midline Glioma Workshop Proceedings', Neuro-Oncology Advances, vol. 2, no. 1, vdaa007. https://doi.org/10.1093/noajnl/vdaa007
2019
Nobre, L, Zapotocky, M, Ramaswamy, V, Ryall, S, Bennett, J, Alderete, D, Guill, JB, Baroni, L, Bartels, U, Bavle, A, Bornhorst, M, Boue, DR, Canete, A, Chintagumpala, M, Coven, SL, Cruz, O, Dahiya, S, Dirks, P, Dunkel, IJ, Eisenstat, D, Conter, CF, Finch, E, Finlay, JL, Frappaz, D, Garre, ML, Gauvain, K, Bechensteen, AG, Hansford, JR, Harting, I, Hauser, P, Hazrati, LN, Huang, A, Injac, SG, Iurilli, V, Karajannis, M, Kaur, G, Kyncl, M, Krskova, L, Laperriere, N, Larouche, V, Lassaletta, A, Leary, S, Lin, F, Mascelli, S, McKeown, T, Milde, T, la Madrid, AM, Morana, G, Morse, H, Mushtaq, N, Osorio, DS, Packer, R, Pavelka, Z, Quiroga-Cantero, E, Rutka, J, Sabel, M, Salgado, D, Solano, P, Sterba, J, Su, J, Sumerauer, D, Taylor, MD, Toledano, H, Tsang, DS, Fernandes, MV, van Landeghem, F, van Tilburg, CM, Wilson, B, Witt, O, Zamecnik, J, Bouffet, E, Hawkins, C & Tabori, U 2019, 'Outcomes of BRAF V600E pediatric gliomas treated with targeted BRAF inhibition', JCO Precision Oncology, vol. 3, pp. 561-571. https://doi.org/10.1200/PO.19.00298